<DOC>
	<DOCNO>NCT00656682</DOCNO>
	<brief_summary>The purpose study determine provide free-of-charge access group-based lifestyle intervention deliver partnership community cost-effective prevention type 2 diabetes .</brief_summary>
	<brief_title>Primary Care Community Partnerships Prevent Diabetes</brief_title>
	<detailed_description>Randomized controlled trial show modest lifestyle change prevent delay onset diabetes adult pre-diabetes . Unfortunately , despite increase prevalence pre-diabetes diabetes facet population , intervention program need achieve goal costly remain unavailable clinical setting . Over past 3 year , demonstrate feasibility training community instructor deliver group-based adaptation Diabetes Prevention Program ( DPP ) lifestyle intervention . In pilot research , new delivery model achieve level weight reduction associate diabetes prevention improve cardiometabolic risk factor control DPP . This new , large-scale randomized effectiveness trial design evaluate cost effectiveness partner approach identify adult pre-diabetes primary care setting , deliver brief advice diabetes prevention , provide access group-based adaptation DPP lifestyle intervention offer community . This study compare cost outcomes standard care , brief clinical counseling approach deliver Registered Dietitians .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<criteria>18 year age old Bodymass index 24 kg/m2 great Fasting Blood Glucose 100 125 mg/dl , OR 2hour Postchallenge Capillary Glucose 140 199 mg/dl Cancer require treatment past 5 year Uncontrolled hypertension : systolic blood pressure &gt; 180 mmHg diastolic blood pressure &gt; 105 mmHg Heart attack , stroke , transient ischemic attack past 6 month , Chronic obstructive airway disease asthma require home oxygen Other chronic disease condition , advance arthritis , could limit ability become physically active limit life span &lt; 5 year Pregnancy Existing diagnosis diabetes mellitus Fasting capillary blood glucose &gt; 125 mg/dl 2hour postchallenge capillary blood glucose &gt; 199 mg/dl History antidiabetic medication use ( oral agent insulin ) except gestational diabetes Selfreport medication know lead hyperglycemia ( oral steroid , antipsychotic , antiepileptic ) Selfreport disease associate disorder glucose metabolism : Cushing 's syndrome ; acromegaly ; pheochromocytoma ; chronic pancreatitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Prevention &amp; Control</keyword>
	<keyword>Hyperglycemia</keyword>
	<keyword>Obesity</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Cost Benefit Analysis</keyword>
</DOC>